| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.4 | 0.01 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |